RFID Barriers to Pharma Adoption: Cost Benefits Standards
Health Industry Insights shares survey findings that identify the top barriers to pharma industry's adoption of radio frequency identification (RFID). 143 life sciences industry leaders point to technology cost, lack of ROI and standards as the barriers. ...

... "The report goes on to spotlight the slower-than-expected RFID adoption with additional survey findings. Results reveal less than one in five (16%) pharmaceutical companies are currently evaluating the benefits of RFID technology, and even fewer (15%) companies adopting RFID in some capacity. Overall, the report indicates average life science company spend on RFID technology is approximately $25,000, although this level is expected to triple to $75,000 over the next 12 months. Additionally, the report discusses read rate results from commercial RFID pilots in the pharmaceutical industry. The report reveals that initiatives utilizing high-frequency (HF) technology for item-level tagging are achieving better read rates than those using ultra-high frequency (UHF). Findings show initiatives using HF are experiencing read rates in the Four to Six Sigma (a well-know management practice used to help companies achieve exceptional performance levels) range, and exceeding Six Sigma in some cases, whereas those using UHF are typically between Three and Four Sigma. " ...
Via Health Industry Insights: Pharmaceutical Industry's Top Roadblocks to RFID Adoption ...
Labels: adoption, barriers, cost, pharmaceutical, rfid-tagging, rfid-technology, roi, standard, survey-results













